Next Article in Journal
Ameliorative Effect of Valeric Acid Against Psychophysiological Chronic Unpredictable Stress
Next Article in Special Issue
Long-Term Inhaled Cannabis Therapy for Chronic Low Back Pain: A Five-Year Retrospective Analysis of Prospectively Collected Patient-Reported Outcomes in 241 Treatment-Refractory Patients
Previous Article in Journal
A Matrix-Free 3D Hepatocyte–Macrophage Co-Culture Spheroid Model for Dual Assessment of Lipid Accumulation and NF-κB-Mediated Inflammatory Activation Under Glucolipotoxic Stress
Previous Article in Special Issue
Sex Differences in the Prevalence of Chronic Pain in Mid-Life: A Systematic Review and Meta-Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Skeletal Fiber Type in Muscle Pain and Dysfunction

by
Maria Lopes Cardia
1,
Bruno Daniel Carneiro
1,2,
Isaura Tavares
1,3 and
Daniel Humberto Pozza
1,3,*
1
Unit of Experimental Biology, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
2
Rheumatology Service, Unidade Local de Saúde do Alto Minho, Hospital Conde de Bertiandos, 4990-078 Ponte de Lima, Portugal
3
Institute for Research and Innovation in Health and IBMC, University of Porto, 4200-135 Porto, Portugal
*
Author to whom correspondence should be addressed.
Biomedicines 2026, 14(4), 794; https://doi.org/10.3390/biomedicines14040794
Submission received: 27 February 2026 / Revised: 24 March 2026 / Accepted: 28 March 2026 / Published: 31 March 2026

Abstract

Different types of skeletal muscle fibers display marked heterogeneity in metabolic, mechanical, and regenerative properties. However, their role in chronic musculoskeletal pain remains insufficiently integrated into clinical models. Chronic pain is associated with altered neuromuscular control, prolonged low-level activation, and reduced recruitment of high-threshold motor units. These factors may promote fiber type-specific remodeling. This narrative review critically synthesizes current evidence on the relationship between musculoskeletal pain and muscle fiber types. The focus was on metabolic vulnerability, mechanical susceptibility, and regenerative capacity. A structured literature search was conducted in PubMed, Scopus, and Web of Science, focused on human studies and key translational models. Chronic musculoskeletal pain is characterized by acquired fiber type-specific adaptations rather than a fixed unfavorable profile. In chronic pain scenarios, Type I fibers present features of chronic overload, including hypertrophy with insufficient capillarization and increased satellite cell activity. Type II fibers exhibit relative disuse, atrophy, and reduced satellite cell content, resembling accelerated muscle aging. Symptom duration, neuromuscular control strategies, and task-specific loading patterns modulate these adaptations, with interindividual variation. Muscle dysfunction in chronic pain reflects maladaptive but potentially reversible neuromuscular and histological plasticity. These findings indicate that rehabilitation strategies should be individualized, involving context-specific exercise strategies to restore muscle structure, function, and regenerative potential in chronic musculoskeletal conditions.

1. Introduction

Skeletal muscle fibers display marked heterogeneity in contractile behavior and metabolism, traditionally divided into slow-twitch (Type I) and fast-twitch (Type II) fibers, with the latter further subdivided into Type IIA or IIX (IIB in small mammals). Fast-twitch fibers are predominantly glycolytic and optimized for phasic, high-power contractions. In contrast, slow-twitch fibers are rich in myoglobin and oxidative enzymes, supporting sustained, low-intensity activity [1,2,3,4].
Histochemical myosin adenosine triphosphatase (ATPase) and oxidative enzyme staining led to the classic classification into slow oxidative (Type I), fast oxidative-glycolytic (Type IIA), and fast glycolytic (Type IIX) fibers. Both Type IIA and IIX (IIB) fibers possess high glycolytic capacity, but they differ in oxidative enzyme content, which underlies their distinct fatigue profiles and metabolic phenotypes [1,2,3,5].
In humans, the modern classification of skeletal muscle fibers is based on myosin heavy chain (MHC) isoforms. Type I fibers express MHC-I, Type IIA express MHC-IIA, and Type IIX express MHC-IIX, whereas adult human skeletal muscle does not express the “true” MHC-IIB isoform found in smaller mammals such as rodents [5,6]. Genetic and electrophoretic analyses from the 1990s onward confirmed that fibers historically mislabeled IIB in humans actually express MHC-IIX, while genuine MHC-IIB expression is restricted to certain non-human species [5,6]. Figure 1 shows a summary of skeletal muscle fiber types.
Under equivalent tension, fast fibers exhibit higher adenosine triphosphate (ATP) consumption than slow-twitch fibers, reflecting their role in rapid, powerful contractions at the cost of energetic efficiency. The spectrum of myosin isoforms determines shortening velocity and power output: slow myosin supports low-velocity, energy-saving contractions, whereas fast isoforms (IIA, IIX) allow for higher velocity and peak power but at greater tension cost [7,8,9].
During intense contraction, ATP turnover can increase up to 1000-fold above resting levels [10], sustained initially by phosphagen systems and then by glycolysis and mitochondrial oxidative phosphorylation. Slow-twitch fibers are better equipped for long-term ATP regeneration via oxidative metabolism and fatty acid utilization, whereas fast-twitch fibers rely more heavily on glycolytic pathways and glycogen stores, making them more powerful but less fatigue-resistant [7,8,9].
At the whole-muscle level, fatigue is expressed as a decline in force, velocity, and power. Muscles enriched in Type II fibers are typically stronger but fatigue faster than those with a higher proportion of Type I fibers [11,12]. Individuals with a predominantly fast-twitch typology exhibit more pronounced high-intensity exercise-induced fatigue and delayed recovery (up to several hours), compared with those with a slow-twitch-dominant profile, who will recover within minutes [11].
Muscle damage can occur when mechanical stress exceeds the structural tolerance of muscle fibers, particularly during unaccustomed or high-force eccentric contractions. Such contractions produce sarcomere overstretching, Z-line streaming, and cytoskeleton disruption, leading to loss of force and activation of inflammatory pathways [13,14]. As structural integrity deteriorates, damage-associated molecular patterns (DAMPs) are exposed, prompting the activation of resident macrophages, mast cells and the subsequent recruitment of circulating leukocytes to the injury site. This immune infiltration amplifies the release of pro-inflammatory cytokines, which not only contribute to debris clearance but also propagate the broader muscle-damage response through enhanced inflammation and oxidative stress [15,16,17]. Severe eccentric loads can induce substantial structural damage and prolonged recovery lasting more than a week, whereas typical resistance-type training elicits only mild myofibrillar disruptions with recovery over a few days [13,18].
Skeletal muscle regeneration depends on satellite cells: quiescent stem cells located between the basal lamina and sarcolemma that activate in response to growth or injury [19,20]. Following muscle damage, satellite cells exit quiescence, proliferate, and differentiate to repair or replace myofibers, a process strongly influenced by both intrinsic factors and signals from the surrounding niche [21,22]. Satellite cell activation increases markedly after resistance exercise, with pair box 7 protein (Pax7) positive cell content rising 24–72 h post-exercise, supporting early phases of muscle repair. Pax 7 protein is essential for maintaining the regenerative capacity of satellite cells, with the coordinated activity of these cells being essential for restoring muscle structure and function after injury [23,24].
Aging is associated with fiber type-specific vulnerability, with a marked decline in Type II fiber size and associated satellite cell content, while Type I fiber size and satellite cell numbers are relatively preserved [19,20]. These age-related changes can be reversed to some extent. In fact, resistance-type training in older adults can increase Type II fiber cross-sectional area and replenish the satellite cell pool, thereby counteracting selective Type II atrophy and enhancing regenerative capacity [25]. In women with chronic trapezius myalgia, specific strength training induces robust expansion of the satellite cell pool and macrophage content in the painful muscle, with satellite cell content per fiber increasing by more than 150% in Type II fibers and by over 50% in Type I fibers [25].
Chronic musculoskeletal pain (CMP), defined in the latest version of the International Classification of Diseases (ICD-11) as pain arising from bone, joint, muscle, or related soft tissues lasting longer than three months, is highly prevalent and often disabling [26]. In 2019, an estimated 2.41 billion people had conditions amenable to rehabilitation, with low back pain representing the most prevalent condition in most countries and contributing substantially to years lived with disability, particularly in middle-aged and older adults and in women [27]. Approximately 1.7 billion prevalent cases of musculoskeletal disorders (MSDs) were reported in 2021, nearly double the number in 1990, with projections exceeding 2.1 billion cases by 2035, despite declining age-standardized mortality rates [28,29]. MSD prevalence rises from childhood to older age, peaking in the 55-year to 89-year range. It is consistently higher in females than males, and is more common in individuals with low and medium socioeconomic status compared with those with higher socioeconomic status [29].
Sex-related differences in muscle fiber morphology and composition are well established. While Type I fibers tend to show similar diameters between men and women, Type II fibers are typically smaller in women, reflecting a sex-specific structural and functional characteristics of fast-twitch fibers. Moreover, men generally exhibit larger cross-sectional areas of both Type I and Type II fibers, as well as a greater proportional area and distribution of Type II fibers. In contrast, women display a higher proportional area and distribution of Type I fibers. These differences persist across age groups, physical activity levels, muscle groups, and analytical techniques, indicating that the divergence in muscle fiber characteristics reflects inherent biological sex differences rather than solely environmental or training-related influences [4,30]. Animal models further indicate sexually dimorphic MHC expression, with males exhibiting a higher proportion of IIB fibers and females a relative predominance of IIA-expressing cells in certain muscles, underscoring hormonal and genetic influences on fiber type distribution [31].
Occupational loading patterns also appear to modulate fiber morphology and pain risk [32,33,34]. In workers exposed to repetitive, low-level static tasks, such as cleaners, a reduction in Type II fiber cross-sectional area in the trapezius has been observed, whereas teachers show larger Type II fibers, possibly reflecting different recruitment patterns of slow and fast units during daily tasks [32,33]. According to the size principle, low-threshold Type I motor units are recruited first and remain active during low-force static work. This formed the basis of the Cinderella hypothesis, which proposes that low-threshold Type I motor units are recruited early during muscle activity and remain continuously active during prolonged low-intensity tasks. Because they are rarely allowed to rest, these fibers may accumulate metabolic stress and structural damage over time, leading to selective overload, structural changes, and chronic myalgia [32,33,35].
Biopsies from chronically painful trapezius muscles revealed a higher proportion of hypertrophied Type I megafibers with poor capillarization compared with healthy controls, suggesting maladaptive remodeling toward large, poorly perfused slow-twitch fibers with increased reliance on anaerobic metabolism [36]. These findings support a model in which prolonged exposure of a limited pool of low-threshold motor units to monotonous static loading produces fiber type-specific structural changes that may contribute to persistent muscle pain. Complementary evidence shows that muscle pain also alters neural control, decreasing firing rates of low-threshold motor units while increasing those of high-threshold units, indicating a differential adjustment of motor-unit recruitment in response to pain [37].
Muscle typology strongly influences responses to high-intensity and eccentric exercise. Fast-twitch fibers are often more susceptible to structural damage, with biomarkers indicating preferential disruption of fast-fiber sarcomeres after high-intensity concentric-eccentric tasks that mimic sprinting and jumping [38,39]. Additionally, it was suggested that in muscles dominated by slow-twitch fibers, the relatively fewer fast fibers may undergo repeated recruitment during eccentric bouts, rendering them especially vulnerable and linking baseline fast-fiber percentage to torque loss and recovery kinetics [38,39].
Isolated fiber experiments indicate that Type IIA fibers can show significant force loss after eccentric protocols, whereas Type I fibers in the same muscle may be relatively spared, further supporting the idea of fiber type-specific susceptibility. However, clinical and biochemical evidence adds further nuance: in mild (grade I) muscle lesions, circulating fast-myosin levels rise disproportionately compared with slow-myosin and blood creatine kinase (CK), suggesting preferential fast-fiber involvement, while more severe (grade II–III) injuries show elevated levels of both fast and slow myosin. These findings highlight that although fast fibers often exhibit greater vulnerability, slow-twitch fibers can also be compromised under certain conditions, underscoring the complexity of fiber type-dependent injury mechanisms [38,40].
Current training paradigms in sport and rehabilitation frequently apply “one-size-fits-all” programs despite clear interindividual differences in muscle typology and fiber type-dependent fatigue and recovery profiles. Evidence indicates that fast- and slow-dominant individuals respond differently to repeated eccentric loading, implying that individualized strength training protocols tailored to fiber type composition could optimize performance, reduce cumulative fatigue, and potentially lower injury and pain risk [11,39,41]. Moreover, fiber type-specific remodeling in chronic pain states, the impact of sex, age, and occupational loading, and the bidirectional relationships between muscle damage, regeneration, and persistent pain are not yet integrated into a coherent, clinically oriented framework. In fact, despite the high prevalence of musculoskeletal pain disorders, most rehabilitation models focus primarily on symptom reduction and functional restoration [42,43,44]. Incorporating a fiber type perspective may therefore provide a more mechanistic framework for understanding how chronic pain alters muscle structure and function and how targeted rehabilitation strategies could address these specific adaptations.
This narrative review synthesizes current evidence on muscle fiber types and muscle pain, with emphasis on their metabolic, mechanical, and regenerative properties, and examines how fiber type biology may inform individualized strategies for the prevention and management of chronic musculoskeletal pain and exercise-induced muscle damage. To support this objective, relevant human studies were identified through structured searches of PubMed/MEDLINE, Scopus, and Web of Science. Priority was given to high-quality studies addressing fiber type heterogeneity, susceptibility to mechanical loading or injury, and clinical correlates of muscle pain, with selected animal data consulted only when necessary for physiological context. This process yielded 27 human studies on muscle pain and muscle injury, which are summarized in Table 1 and Table 2.

2. Satellite Cells and Muscle Damage

Human studies investigating satellite cells commonly rely on muscle biopsy techniques combined with histological and immunohistochemistry analyses to assess cellular content, activation, and fiber type-specific responses. In patients who had previously been exposed to monotonous and repetitive work tasks, strength training led to a marked increase in satellite cell content. This increase amounted to approximately 65% in Type I fibers and 164% in Type II fibers, indicating a stronger regenerative response in fast-twitch fibers [25].
Muscle damage involved both fiber types, though patterns differed: structural damage was evident in Type I fibers of patients with monotonous and repetitive work tasks with trapezius myalgia (19% more of satellite cells per fiber than Type II fibers) [45], containing a significantly higher proportion of Type I megafibers (grossly hypertrophied Type I muscle fibers) with poor capillarization [36], while exercise-induced disruption indicated substantial Type II fiber involvement [39,62].
In eccentric and concentric-eccentric exercise, Type II fibers were damaged first, showing sarcomere disruption and reduced force production (about 8% decrease in Type IIA peak force), while Type I fibers were initially spared [62]. Although, in eccentric exercise-induced muscle damage, clear damage was seen in Type I fibers, yet CK levels imply that Type II fibers were also involved, likely to a comparable extent [65]. In summary, satellite cell responses and muscle damage patterns highlight fiber type differences. Type II fibers show strong regenerative activation but are highly susceptible to early disruption, whereas chronic occupational loading predominantly affects Type I fibers, leading to structural changes.

3. Symptom Duration and Fiber Composition

The relationship between symptom duration and lumbar muscle morphology in chronic low back pain (CLBP) suggests time-dependent but heterogeneous, remodeling of muscle fibers. Several consistent patterns and important contradictions emerge from available studies.
Longer symptom duration has been associated with a shift toward a more glycolytic profile, specifically an increased proportion of Type IIX fibers and a concurrent reduction in Type I fibers [55]. Prolonged pain has also been linked to the appearance of Type I megafibers, consistent with maladaptive structural remodeling over time [36]. However, overall cross-sectional muscle area (RCSA) does not consistently correlate with symptom duration [67], and preliminary data indicate that the presence of at least one cytochemical alteration in fiber architecture may be associated with longer pain duration, an observation that requires confirmation in longitudinal studies [55].
Type IIC fibers are normally rare and remain uncommon in CLBP. When present, Type IIC proportions tend to be higher in early-stage pain (<1 year) and lower in long-standing pain (>3 years), which is compatible with an early, transient phase of fiber type transition following symptom onset [53,55]. This temporal pattern of early transformation was also observed in chronic neck pain, where a higher proportion of transitional Type IIC fibers was found almost exclusively in patients with symptoms lasting less than 16 months. In contrast, patients experiencing pain for more than 20 months lacked Type IIC fibers [50].
Morphological and pathological changes in the lumbar multifidus have also been reported. Higher pain intensity and greater disability correlate with smaller Type I fibers in the lumbar region [52,67]. In patients with disc herniation undergoing microdiscectomy, the multifidus frequently contained a greater proportion of pathological fibers, including focal myofibrillar degeneration [52]. Fiber atrophy affects both Type I and Type II fibers but is often more pronounced in Type II fibers, with probable consequences for force generation. Importantly, fiber atrophy in these cohorts was linked to objective signs of nerve-root involvement rather than to symptom duration, implying that denervation and ischemia, rather than simple deconditioning, may drive morphological deterioration in specific pathologies such as disc herniation [52,67].
Findings on fiber type distribution across studies are inconsistent. Some reports identify a reduction in Type IIB/IIX fibers and a relative shift toward a more oxidative phenotype (larger Type I RCSA and smaller Type IIB/IIX RCSA) [54], whereas others describe an increased proportion of Type II fibers, particularly Type IIB/IIX, together with reduced fiber diameters across both Type I and II fibers [51,53]. These discrepancies likely reflect differences in patient populations, symptom duration, underlying pathology (for example, nerve-root compression), and methodological approaches.
In summary, chronic pain is associated with complex, time-dependent changes in fiber composition and morphology: early transitional changes (including transient Type IIC increases), later shifts in fiber type proportions, and pathology-specific atrophy driven in some cases by denervation/ischemia. In Figure 2, we propose a conceptual model related to CMP.

4. Muscle Fiber Size and Atrophy

Differences in muscle fiber size were investigated in patients with fibromyalgia (FM). No significant differences were observed in the overall proportion of Type I and Type II muscle fibers between FM patients and controls. However, patients with FM exhibited pronounced alterations in muscle fiber morphology, characterized by greater variability in fiber size and a disrupted fiber size distribution. Specifically, there was an increased prevalence of small-diameter fibers, particularly among Type II fibers, suggesting selective involvement or impaired maintenance of fast-twitch fibers. In addition to these structural changes, capillary density was reduced in individuals with FM, which may reflect compromised muscle perfusion and is likely to contribute to impaired muscle metabolism and reduced functional capacity [57]. Overall, FM preserves overall fiber type proportions but shows more small Type II fibers, greater fiber size variability, and reduced capillary density, indicating impaired muscle maintenance and perfusion.

5. Physical Activity, Occupation and Loading Patterns

The influence of physical activity level and occupational loading on multifidus muscle fiber characteristics has been investigated to better understand muscle adaptation to different functional demands. Overall, the level of physical activity did not appear to influence multifidus muscle fiber characteristics. Specifically, muscle fiber type composition and distribution did not differ significantly among individuals with high, medium, or low levels of physical activity [51].
In contrast, clear differences were observed in relation to occupational loading. Cleaners exhibited a smaller RCSA of Type II fibers compared with teachers, while no differences were found in Type I fibers. Similarly, female office workers with trapezius myalgia showed higher proportions of Type IIA fibers and lower proportions of Type I fibers compared to healthy controls [49]. These findings likely reflect distinct muscle activation patterns and mechanical demands associated with different occupational tasks, suggesting that sustained, occupation-specific loading may selectively influence fast-twitch muscle fiber morphology [32].

6. Sex and Age Differences

Sex- and age-related differences in muscle fiber characteristics have been examined in patients with chronic low back pain to better understand variability in muscle adaptation and pathology. In this context, men were found to exhibit a higher proportion of Type IIX fibers and a larger muscle fiber diameter compared with women [51], whereas women showed a greater proportion of Type I fibers [55].
Additionally, women demonstrated fewer Type IIC fibers and a higher prevalence of Type I megafibers, particularly in conditions such as trapezius myalgia. These alterations were often accompanied by poor capillarization, suggesting impaired muscle perfusion and potential metabolic consequences [36,55]. Conversely, men with work-related trapezius myalgia exhibit a different morphological response, characterized by Type IIA fiber hypertrophy accompanied by a proportional increase in capillary supply, as well as histological signs of an active muscle injury-regeneration cycle [48]. Furthermore, during experimentally induced trapezius pain, women showed a less effective protective decrease in muscle activity and lacked the adaptive recruitment of additional motor units seen in men during sustained painful contractions [68].
Age was not found to exert a significant influence on muscle fiber characteristics in patients with chronic low back pain. However, there was a tendency for increasing age to be associated with smaller overall muscle fiber size, especially among Type II fibers, along with a shift toward higher proportions of Type I fibers and reduced proportions of Type IIX fibers. These trends may reflect age-related remodeling and a gradual transition toward a more oxidative muscle phenotype [55].
Sex-related differences in muscle fiber size appear to develop during the transition from childhood to adulthood, and particularly during adolescence, associated with hormonal changes. In adults, males typically show larger cross-sectional areas in fast Type II fibers, particularly Type IIA, relative to Type I fibers, a pattern not observed in children. Much of the variation in Type II fiber size is explained by body weight and sex, whereas Type I fiber size is primarily related to body weight alone. These findings suggest that sex-specific muscle characteristics emerge with maturation, likely reflecting combined effects of growth, physical activity patterns, and hormonal changes [69]. In summary, sex influences muscle morphology: men tend to show a higher proportion of Type II fibers and larger fiber diameters, whereas women show more Type I fibers and a higher prevalence of Type I megafibers with poorer capillarization. Age exerts mild effects, generally trending toward smaller fibers and a more oxidative profile.

7. Regional Differences

Muscle fiber composition and motor unit recruitment patterns have been investigated in relation to muscle depth and pain-related motor control alterations. The deep layers of the multifidus muscle were found to be predominantly composed of Type I fibers compared with the more superficial layers. However, despite this structural distinction, no evidence of differential muscle fiber recruitment was observed during trunk extension tasks performed with or without experimentally induced pain [60]. Moreover, morphological investigations in patients with chronic lumbar spine pathology demonstrate that the superficial and deep regions of the multifidus undergo similar structural alterations, with no significant differences in fiber type composition, fiber cross-sectional area, or the extent of muscle degeneration between layers. Both regions appear to be equally affected by the pathological process [56].
In contrast, functional alterations in motor unit behavior were evident during repeated eccentric exercise bouts, where reduced activation of fast-twitch motor units was observed. This pattern may reflect the presence of an adaptive inhibitory mechanism, potentially serving to protect already stressed or damaged muscle tissue from further mechanical strain and injury [64].
The etiology of paraspinal muscle dysfunction appears to be related more to acquired adaptations than to an inherent or constitutionally adverse muscle fiber type profile. Specifically, no abnormalities have been identified in paraspinal muscle fiber size, fiber type composition, or overall fiber content that would suggest a primary structural predisposition [61].
Instead, evidence points toward activity- and load-related changes affecting muscle fiber integrity. Early overload and damage to Type I fibers were accompanied by an increase in satellite cell content and myonuclei, indicative of an active regenerative response. In contrast, Type II fibers exhibited reduced satellite cell content and greater degrees of atrophy, likely reflecting relative underuse or altered recruitment patterns [45]. Moreover, the absence of α-actinin-3 was associated with increased susceptibility to damage in Type II fibers, highlighting a potential genetic influence on fiber-specific vulnerability [63].
Supporting the concept of acquired pathology, a case series report described multifocal myofibrillar disorganization selectively affecting Type II fibers, further underscoring the role of secondary, load-dependent mechanisms in the development of paraspinal muscle dysfunction [59]. In this context, muscle dysfunction appears driven by acquired, load-related changes rather than inherent fiber type differences, with protective reductions in fast-twitch motor unit activation during repeated eccentric tasks and greater vulnerability of Type II fibers to damage.

8. Lean Body Mass

The relationship between muscle fiber size and body composition has been examined to better understand determinants of muscle morphology. Muscle fiber diameter was found to be strongly correlated with lean body mass, particularly for Type II fibers [42]. In line with these findings, lean body mass showed a significant positive correlation with the size of Type IIA and Type IIX fibers [55], suggesting that greater muscle mass is primarily associated with hypertrophy of fast-twitch and intermediate fiber types.
Moreover, these correlations help explain sex-related differences in fiber size, as males typically have greater lean mass and correspondingly larger Type II fibers than females, reinforcing the role of both body composition and sex in shaping muscle morphology [69].
A summary of the key differences among muscle fiber types is presented in Table 3.

9. Discussion

The present findings demonstrate that chronic musculoskeletal pain (CMP) is associated with fiber type-specific alterations in skeletal muscle morphology and regenerative behavior, rather than reflecting a constitutionally predetermined fiber type profile. This response accompanied by greater damage and atrophy in fast-twitch fibers, the presence of hypertrophied yet poorly capillarized Type I megafibers linked to chronicity, and the rare, transient appearance of Type IIC fibers together suggest distinct adaptive strategies to chronic overload and functional alterations.
The increase in satellite cell content following specific strength training, more than twofold greater in Type II than in Type I fibers, indicates that the trapezius muscle affected by chronic myalgia retains a substantial regenerative potential [25,70]. This is especially relevant because, prior to intervention, patients with chronic pain frequently exhibit a selective satellite cell deficit in Type II fibers [45], a pattern that resembles accelerated muscle aging [71]. The aging process is typically characterized by a preferential shift from fast-twitch to slow-twitch fibers, a reduction in Type II fiber-associated satellite cell pools, and progressive intramuscular fat infiltration, processes that may be further exacerbated by metabolic dysregulation and insulin resistance promoting ectopic lipid accumulation and impaired muscle glucose metabolism [72,73,74]. The pronounced satellite cells expansion in fast-twitch fibers after training, even in elderly (and probably in sedentary, overweight/obese subjects), suggests that targeted loading can partially reverse this imbalance and restore the myogenic capacity of these fibers [24,25]. This finding challenges the hypothesis that chronically overloaded Type I fibers in occupational settings become refractory to further myogenic stimuli.
Skeletal muscle is a highly plastic tissue that adapts to contractile demand and environmental conditions, resulting in coordinated changes in metabolism, contractile properties, and fiber type composition. Endurance exercise, largely via activation of the transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α), promotes oxidative metabolism, shifts fibers toward fatigue-resistant phenotypes, enhances vascularization, and protects against muscle atrophy. Beyond metabolic remodeling, exercise and PGC-1α also modulate the muscle stem cell niche and immune environment, influencing satellite cell activity and macrophage polarization in ways that support muscle maintenance and regeneration. Importantly, the observed expansion of satellite cells and concomitant increase in macrophage content occur in the absence of classical markers of muscle damage or regeneration (e.g., centralized nuclei or embryonic myosin) [58], indicating that these cellular changes represent a beneficial physiological adaptation and pre-conditioning of muscle rather than a repair response to exercise-induced injury. This adaptive response was also associated with reductions in clinical pain, supporting a link between improved regenerative capacity and symptom improvement [16,75].
These findings align with growing evidence that exercise-induced cellular responses can foster a regenerative immune environment without provoking maladaptive tissue damage. Acute exercise, particularly when involving high mechanical strain, transiently recruits immune cells such as neutrophils, macrophages, and lymphocytes to muscle, where coordinated inflammatory signaling supports debris clearance, resolution of inflammation, and tissue repair. A timely transition of macrophages from pro-inflammatory to anti-inflammatory and pro-regenerative phenotypes is critical for effective regeneration and prevention of fibrosis, whereas persistent or dysregulated inflammation contributes to muscle degeneration and is implicated in conditions such as sarcopenia, insulin resistance, and muscular dystrophies. Regular moderate exercise appears to modulate immune cell infiltration and polarization in a manner that enhances repair while limiting chronic inflammation. Together, these observations suggest that when exercise elicits controlled satellite cell and immune cell activation without overt muscle damage, it supports muscle regeneration, functional improvement, and symptom relief, underscoring the importance of context-specific, well-regulated exercise interventions in chronic muscle disorders [17,76].
In patients performing monotonous and repetitive tasks, namely in the work context, greater satellite cells content in Type I fibers compared with Type II fibers [45] supports the Cinderella hypothesis, which proposes that low-threshold motor units are continuously recruited and subjected to chronic metabolic stress. This persistent activation may stimulate satellite cells expansion and myonuclear accretion to sustain protein turnover. In the myonuclear accretion phenomenon satellite cells proliferate and can fuse with existing fibers, contributing additional nuclei, which supports fiber repair and hypertrophy [77,78].
The presence of Type I megafibers in the same individuals [36] further suggests that these fibers belong to chronically activated motor units. On the other hand, experimental and modeling data suggest that motor units in postural muscles are recruited in rotation rather than in a fixed hierarchical manner, which would theoretically prevent the formation of permanently overloaded muscular units. Within this framework, factors that predispose to myofascial pain, such as increased muscle load or reduced muscle strength, can shorten motor unit relaxation periods and limit energetic recovery despite rotational recruitment. These conditions may impair the normal cycling of activation and deactivation that allows fibers to share mechanical demands. As a result, sustained tasks may lead to inefficient load distribution and accelerated fatigue. Thus, even in the absence of continuously active motor units, insufficient relaxation time under sustained load may still drive an energy crisis, providing an alternative mechanism by which chronic low-level activity can induce metabolic stress and muscle pathology [79,80]. Recent evidence further refines this concept by linking sustained low-level muscular activity to a cascade of metabolic and nociceptive events that promote peripheral sensitization. Prolonged or repetitive contraction can impair local perfusion, leading to relative ischemia, ATP depletion, mitochondrial dysfunction, and accumulation of metabolites such as lactate, protons, and inflammatory mediators. These metabolic disturbances activate and sensitize group III and IV muscle afferents nerve fibers, which in turn enhance nociceptive signaling and promote neurogenic inflammation. The resulting microenvironment favors persistent nociceptor activation, altered ion channel function, and local release of pain-evoking substances, creating a self-sustaining cycle of metabolic stress and peripheral sensitization [80,81,82,83]. In this context, muscle pain associated with repetitive low-load activity is not solely explained by permanent recruitment of specific motor units, but rather by the interaction between insufficient energetic recovery, microcirculatory compromise, inflammatory signaling, and nociceptor sensitization. Consequently, this framework integrates motor unit recruitment patterns with metabolic vulnerability and peripheral neural sensitization, offering a more comprehensive explanation for how chronic low-intensity muscle activity may evolve into persistent myofascial pain states [80,84,85,86].
Experimental models of exercise-induced muscle damage indicate preferential involvement of Type II fibers during eccentric and combined concentric-eccentric contractions, as reflected by early force loss and structural disruption [62,64,87]. This vulnerability likely arises from the lower intrinsic resistance of fast-twitch fibers to eccentric strain. In individuals with a predominantly Type I fiber composition, repeated recruitment of a limited pool of Type II fibers during initial exercise bouts may exacerbate damage in these fibers and contribute to torque loss [12,39]. Nevertheless, Type I fibers are not exempt from damage, as an exercise performed to task failure, regardless of load magnitude or repetition duration, ultimately necessitates recruitment of both Type I and Type II motor units. Consequently, when contractions are continued to volitional fatigue, metabolic stress and fiber activation extend across the full motor unit pool, making both fiber types susceptible to exercise-induced strain and contributing to early functional impairment during unaccustomed training [66].
In eccentric exercise, clear structural alterations have been observed in Type I fibers, while creatine kinase (CK) levels imply that Type II fibers are similarly involved [65]. This suggests that eccentric-induced muscle stress is not restricted to a single fiber type, but is mediated through multiple pathways, including excitation-contraction coupling disturbances, increased sarcolemma permeability, and extracellular matrix disruption. Apart from CK, these processes are accompanied by the plasma release of inflammatory and nociceptive mediators such as bradykinin, interleukins, tumor necrosis factor, nerve growth factor, and glial cell line-derived neurotrophic factor, as well as elevated reactive oxygen and nitrogen species. Together, these molecular responses contribute to delayed-onset muscle soreness, mechanical hyperalgesia, and transient impairments in muscle function following eccentric loading. These findings indicate that susceptibility to eccentric-induced muscle stress is not governed by a fixed fiber type hierarchy, but rather is context-dependent and shaped by contraction mode, motor unit recruitment strategies, mechanical loading characteristics, and baseline muscle fiber composition [18,88].
A study using multivariate models indicated that, with age and influenced by sex, symptom duration accounted for nearly 30% of the variance in fiber type distribution, with longer duration associated with a shift toward a more glycolytic profile, namely, higher proportions of fast-fatigable Type IIX fibers while Type I fibers decrease. Notably, symptom duration did not influence fiber size. Gross trunk muscle relative cross-sectional area (RCSA) correlated positively with lean body mass and negatively with age but showed no relationship with symptom duration. Cytochemical architectural abnormalities were more common in older patients and were independent of pain duration [55]. Collectively, these findings indicate that long-term adaptations in chronic low back pain primarily involve fiber type transitions rather than fiber atrophy, consistent with increased muscle fatigability and underscoring the importance of early active interventions [53,55,89].
Sex and age significantly influence fiber type distribution in chronic low back pain. Men exhibit a higher proportion of Type IIX fibers than women, largely attributable to differences in lean body mass, which account for up to 64% of variance in trunk muscle RCSA [55,69]. In parallel, aging is typically characterized by reductions in Type II fibers, associated satellite cell pools, and progressive intramuscular fat infiltration, changes that are further exacerbated by systemic metabolic dysregulation, particularly insulin resistance, which promotes ectopic lipid accumulation and impaired muscle glucose metabolism [72,73,74]. These aging-related alterations share several features with the muscle changes observed in chronic pain, including preferential Type II fiber atrophy, diminished Type II associated satellite cell content, and increased intramuscular fat. However, key distinctions remain: whereas aging reflects global, systemic physiological processes, CMP-related adaptations appear to arise primarily from localized overload, underuse, or altered fast-twitch motor-unit recruitment rather than from systemic metabolic or endocrine drivers. In CMP, these changes are more strongly linked to task-specific mechanical stress, reduced activation of fast-twitch motor units, and fiber-specific vulnerability (for example, in individuals lacking α-actinin-3), underscoring that the pathology is primarily acquired and load-dependent rather than constitutional [90,91,92,93].
In addition, sex-related differences in muscle fiber characteristics emerge during maturation, with adult males typically exhibiting larger cross-sectional areas in fast Type II fibers compared with Type I fibers, a pattern not observed in females or children and largely explained by differences in body mass and sex-related factors. Transitional fibers (Type IIC) are expected to be more prevalent in men, although their absolute proportion remains low, reinforcing the interpretation that fiber type adaptation in chronic low back pain is slow and cumulative rather than acute [55,69]. While normal aging reduces Type IIX fibers [94], prolonged chronic low back pain appears to override this tendency, promoting a relative increase in glycolytic fibers [55]. Thus, chronic pain may mask, or reverse expected age-related shifts in fiber type composition.
Interestingly, these sex-specific structural adaptations extend beyond the lumbar region and appear to be muscle-specific, as evidenced in the trapezius. While women with work-related trapezius myalgia tend to develop Type I megafibers with deficient capillarization, men exhibit a completely different morphological response, developing Type IIA fiber hypertrophy accompanied by a proportionally matched capillary network [48]. This divergence is not merely structural but also functional. A study demonstrated that during experimentally induced pain, women lack the protective neuromuscular adaptation seen in men, who recruit additional motor units to cope with fatigue. Consequently, this less efficient motor control, combined with the female prevalence of poorly capillarized Type I megafibers, further explains women’s higher vulnerability to work-related myalgia compared to the more robust compensatory mechanisms observed in men [68].
The scarcity of transitional Type IIC fibers further implies that fiber type conversion occurs slowly and continuously or that biopsies capture a stabilized post-transformation state rather than an acute remodeling phase [53,55,69]. This concept of a stabilized post-transformation state is strongly corroborated by findings in the cervical spine. Active fiber transformation occurs mainly during the first 2 years of neck pain. After this initial phase, the neck muscles return to a structurally stable condition, ceasing further fiber transformation despite the continuation of cervical dysfunction and chronic pain [50]. Importantly, while chronicity influences fiber type proportions, it does not determine fiber size, which is primarily dependent on lean mass. Highly oxidative fibers tend to remain smaller despite a high capacity for protein synthesis, due to competing signaling demands between myofibrillar protein accretion and mitochondrial biogenesis, as well as higher proteasome-mediated protein degradation. Thus, fiber size appears to be regulated predominantly by systemic factors such as mechanical loading and lean body mass, rather than by symptom duration or pain chronicity [55,95]. Moreover, degenerative alterations in internal fiber architecture appear to be more strongly associated with biological aging than with pain duration per se [53,55].
Consistent with this, Zhao et al. [67] found no relationship between symptom duration and multifidus RCSA but demonstrated that fiber atrophy was linked to objective signs of nerve root involvement. This suggests that denervation and ischemia, rather than cumulative deconditioning alone, drive morphological deterioration in specific pathologies such as disc herniation [52,67]. Patients with smaller Type I fibers exhibited greater pain and disability, supporting the notion that atrophy of tonic stabilizing fibers compromises segmental control of the spine [96]. In trapezius myalgia, selective hypertrophy of Type I fibers (megafibers) has been reported in women, consistent with chronic activation of low-threshold motor units [36]. However, this hypertrophy is not accompanied by proportional angiogenesis, resulting in deficient capillarization. The mismatch between fiber volume and oxygen supply may promote local hypoxia and anaerobic metabolism, favoring the accumulation of nociceptive metabolites and perpetuation of chronic pain [97]. However, this microcirculatory impairment and metabolic dysfunction appear to be reversible. Both strength and endurance training can significantly increase the number of capillaries around Type I and IIA fibers in myalgic trapezius muscles. By improving the capillary supply, these interventions enhance oxygen delivery to the working muscle fibers, effectively mitigating the local energy crisis and contributing to significant pain relief [46].
Comparisons across studies reveal conflicting patterns of fiber type transformation in low back pain [98]. Earlier studies reported a shift toward a glycolytic phenotype with increased Type II fibers and pronounced atrophy [51,53,67], whereas more recent work has shown preservation or even predominance of Type I fibers with reductions in Type IIX fibers [54]. These discrepancies can be explained by differences in pain etiology and adaptation mechanisms. First, clinical populations differ substantially. Studies reporting glycolytic shifts largely investigated patients with structural pathology (disc herniation, stenosis, scoliosis), where denervation and ischemia directly influence fiber morphology [67]. Supporting this distinction, in patients undergoing surgery for severe structural pathologies (such as stenosis and herniation), the multifidus muscle exhibits profound global degeneration, elevated fibrosis, and persistent signs of muscle damage that outpace regenerative capacity. This reinforces that nerve compression and structural severity drive morphological deterioration [56]. In contrast, investigations of non-specific chronic low back pain [54] reflect adaptations in the absence of nerve compression. Second, competing adaptation mechanisms may operate: classic disuse favors fast, fatigable fibers [51], whereas altered neuromuscular control in non-specific chronic low back pain may produce tonic, low-frequency activation patterns [99] that induce slow fiber transformation (IIX > IIA > I) [100]. Thus, muscle remodeling appears contingent on both clinical subgroup and motor control strategy.
Deep multifidus fibers were found to be predominantly Type I compared with superficial layers, reflecting their postural function. However, no consistent differences in recruitment have been observed during trunk extension with or without experimentally induced pain. Evidence from eccentric exercise suggests preferential recruitment and disruption of Type II fibers [62,87], and reduced fast motor unit recruitment during repeated bouts may represent an adaptive inhibitory mechanism that protects previously damaged fibers [64]. On the other hand, the clinical hypothesis that the deep multifidus is uniquely susceptible to structural degeneration in chronic pain conditions is not supported by other studies. A study in patients with chronic lumbar spine pathology demonstrated that degenerative changes, including fiber atrophy, shifts in fiber type composition, and fat infiltration, occur to a similar extent in both the superficial and deep regions, rather than selectively affecting the deep layer [56]. Interestingly, this lack of motor control adaptation in the lumbar region contrasts with findings in the cervical region. When experimental pain was induced in the upper trapezius, individuals (particularly men) effectively altered their motor strategy by recruiting additional motor units to cope with fatigue. This discrepancy suggests that neuromuscular adaptations to acute pain are highly region-specific, depending heavily on the biomechanical role of the muscle and the individual’s sex [68].
Muscle morphology is sensitive to occupational demands. Cleaning workers exhibit smaller Type II fibers RCSA compared with teachers, without changes in Type I fibers, indicating that static and repetitive low-force tasks selectively fail to preserve fast-twitch fiber size [32]. This adaptation is also evident in sedentary professions. It was observed that office workers with trapezius myalgia shift toward a faster, glycolytic profile (increased Type IIA and decreased Type I fibers), likely a metabolic adaptation to local hypoxia caused by prolonged static computer work. Furthermore, both myalgic and healthy workers exhibited enlarged Type I fibers, strongly supporting the Cinderella Hypothesis which states that continuous low-level tasks chronically overload low-threshold motor units [49]. In contrast, overall physical activity level does not appear to influence fiber type distribution or diameter in multifidus muscles [51]. This suggests that generalized activity is insufficient to counteract pain-related inhibition and abnormal motor control, which may perpetuate histological damage through reduced reflex activation and abnormal loading patterns [101,102,103].
Genetic variation in α-actinin-3 influences fiber type-specific responses to eccentric loading. Individuals expressing α-actinin-3 (recessive-recessive genotype) exhibit increased stiffness specifically in Type IIA fibers after eccentric exercise, potentially conferring Z-disc protection [104]. This viscoelastic adaptation may reduce sarcomere overstretch and limit structural disruption in subsequent exposures [62]. However, protective effects appear modest and context-dependent [63]. In fact, genetic variability may influence individual differences in muscle fiber composition, regenerative potential, and susceptibility to musculoskeletal pain [105,106,107]. Although the genetic contribution to chronic musculoskeletal pain remains incompletely understood, future studies integrating genetic and molecular analyses may provide further insight into interindividual variability in muscle remodeling and recovery.
In FM, most muscle biopsy studies do not demonstrate consistent differences in overall muscle fiber type proportions when compared with healthy controls [108]. It is possible that the increased heterogeneity in muscle fiber morphology is characterized by marked variability in fiber size and a higher prevalence of small-diameter fibers, particularly among Type II fibers [57]. These alterations probably occur in the absence of overt inflammatory changes and are not specific enough to define a primary myopathic process. The selective involvement of Type II fibers, together with reports of reduced capillary density and microvascular abnormalities, may nevertheless compromise oxygen delivery and metabolite clearance during muscle activity. Such peripheral alterations could contribute to post-exercise fatigue, pain, and exercise intolerance in FM, even though they are likely secondary and interact with central pain-processing mechanisms rather than constituting a primary cause of the syndrome. Thus, these peripheral muscle alterations are best interpreted within a broader pathophysiological context in which FM is conceptualized as a centralized pain syndrome, driven by dysregulation of central nervous system processing, impaired descending pain modulation, neuroinflammation, and neurotransmitter imbalances. Accordingly, muscle changes are likely secondary or contributory factors that interact with central sensitization mechanisms, rather than constituting a primary myopathic cause of the disorder [109].
Taken together, these findings indicate that muscle dysfunction in chronic pain does not arise from an inherently adverse fiber type profile but from acquired, fiber-specific maladaptations. Type I fibers exhibit features of chronic overload and compensatory satellite cells expansion, whereas Type II fibers display patterns consistent with disuse, satellite cells depletion, and atrophy, resembling premature muscle aging. This remodeling can occur without marked inflammatory activation, suggesting a chronic homeostatic rather than acute injury response. Therefore, rehabilitation strategies should move beyond nonspecific activity and incorporate targeted loading of fast-twitch fibers to reverse atrophy and fatigability, while simultaneously promoting oxidative capacity to improve endurance and metabolic efficiency. In humans, where muscle fiber types exhibit relatively similar cross-sectional areas, interventions that enhance oxidative adaptations, through appropriately dosed endurance training, combined modalities, or adjunct nutritional and pharmacological strategies, may improve fatigue resistance without compromising muscle mass. Importantly, preservation and reconditioning of Type II fibers remain essential for maintaining strength, power, and functional capacity, underscoring the need for balanced, fiber type-specific rehabilitation programs that support both metabolic health and neuromuscular performance [110,111,112,113].
Clinical interventions should extend beyond generic strengthening and flexibility programs to include strategies that specifically target fast-twitch fibers, counteracting Type II atrophy and restoring force-generating capacity, while also enhancing oxidative metabolism and perfusion in slow-twitch fibers—particularly in muscles subjected to sustained low-level activation. Additionally, interventions should incorporate exercise modalities that stimulate satellite cell activity, promoting adaptive regeneration and long-term muscle resilience [64,114,115]. In FM, combined aerobic and resistance training may be required to address both reduced capillarization and fiber size heterogeneity. This combined approach appears to be the most effective for improving quality of life, alleviating pain, and enhancing physical function in individuals with the disease. Supporting this, a network meta-analysis of 51 RCTs gathering 2873 women with FM found that aquatic exercise was most effective in reducing pain in the short term, while resistance training showed the greatest benefits in the long term. These findings highlight the importance of incorporating both aerobic and resistance modalities to achieve sustained therapeutic effects in FM [114,116]. In fact, it is suggested that progressive resistance training performed two to three times per week at moderate-to-high intensity is particularly effective in stimulating hypertrophy and functional recovery of Type II fibers. In contrast, aerobic training at moderate intensity appears to primarily support oxidative capacity and capillarization of Type I fibers [117,118,119,120,121].
It has also been demonstrated that active rehabilitation strategies are effective in the management of chronic musculoskeletal pain. There are superior clinical outcomes with predominantly active physiotherapy approaches compared with passive or combined modalities in chronic low back pain. These findings are consistent with the concept that mechanical loading and muscle activation are essential stimuli for restoring muscle fiber function and reversing disuse-related adaptations [42,122,123,124].
The heterogeneity of findings across studies likely reflects methodological and clinical variability. Differences in patient populations, symptom duration, occupational loading patterns, and biopsy location may significantly influence fiber type composition. In addition, methodological factors such as fiber-typing techniques, immunohistochemistry protocols, and sample size may contribute to inconsistent observations. Finally, chronic musculoskeletal pain represents a heterogeneous group of conditions with distinct pathophysiological mechanisms, which may further explain the variability reported in the literature.
Future research should prioritize translational models that integrate detailed muscle histology with functional neuromuscular assessments, including high-density surface electromyography, in vivo imaging of muscle quality, and reflex pathway evaluation during dynamic tasks. Incorporating artificial intelligence and machine learning approaches could further enhance data analysis, enabling real-time prediction of fiber type recruitment, personalized exercise prescription, and identification of the most effective interventions to optimize muscle adaptation and regeneration [99,125,126,127,128]. Longitudinal studies stratifying patients by motor control strategy, pain phenotype, and treatment response are needed to identify subgroups with differential muscle adaptation trajectories. Incorporation of molecular biomarkers of regeneration, including satellite cell activity and growth factor signaling, may further clarify mechanisms of muscle plasticity in chronic pain. Ultimately, pragmatic clinical trials should evaluate whether interventions tailored to fiber type-specific vulnerabilities (e.g., fast-fiber-targeted strength training versus oxidative conditioning of postural muscles) improve patient-centered outcomes such as function, work ability, and quality of life.

10. Conclusions

Skeletal muscle exhibits remarkable plasticity, with fiber type composition, metabolic profile, and regenerative capacity shaped by age, sex, physical activity, and pathological conditions. In chronic musculoskeletal disorders, including chronic low back pain and fibromyalgia, maladaptive changes, such as Type II fiber atrophy, reduced oxidative capacity, altered perfusion, and impaired satellite cell function, contribute to diminished force production, increased fatigability, and functional decline. Exercise interventions, particularly those combining aerobic and resistance modalities, can counteract these changes by promoting fast-twitch fiber recruitment, enhancing oxidative metabolism in Type I fibers, and stimulating satellite cell-mediated regeneration. Translational evidence highlights that these adaptations occur even in the absence of overt muscle damage, supporting the concept of exercise-induced pre-conditioning for improved regenerative capacity. Sex- and age-related differences, along with lean body mass, modulate these responses, emphasizing the need for individualized, context-specific exercise strategies to restore muscle structure, function, and regenerative potential in chronic musculoskeletal conditions. Integrating molecular profiling of satellite cells and muscle fibers may help clarify the mechanisms underlying impaired regeneration and fiber type remodeling.
From a clinical perspective, these findings support the development of individualized rehabilitation programs that specifically target fiber type deficits, combining resistance training to restore Type II fiber function with endurance-based strategies to optimize oxidative capacity and microvascular adaptations.

Author Contributions

Conceptualization, M.L.C., I.T. and D.H.P.; investigation, M.L.C., B.D.C. and D.H.P.; imaging, B.D.C.; writing—original draft preparation, M.L.C. and B.D.C.; writing—review and editing, M.L.C., B.D.C., I.T. and D.H.P.; project administration, I.T. and D.H.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study.

Conflicts of Interest

The authors have no relevant financial or non-financial interests to disclose.

Abbreviations

The following abbreviations are used in this manuscript:
ACTN3α-actinine-3 gene
ATPadenosine triphosphate
ATPaseadenosine triphosphatase
CKblood creatine kinase
CMPchronic musculoskeletal pain
DAMPsdamage-associated molecular patterns
ELISAenzyme-linked immunosorbent assay
FMfibromyalgia
MHCmyosin heavy chain
MSDmusculoskeletal disorder
Pax7pair box 7 protein
PGC-1αperoxisome proliferator-activated receptor γ coactivator 1α
RCSArelative cross-sectional area

References

  1. Siracusa, J.; Koulmann, N.; Sourdrille, A.; Chapus, C.; Verret, C.; Bourdon, S.; Goriot, M.E.; Banzet, S. Phenotype-Specific Response of Circulating miRNAs Provides New Biomarkers of Slow or Fast Muscle Damage. Front. Physiol. 2018, 9, 684. [Google Scholar] [CrossRef]
  2. Tellis, C.M.; Rosen, C.; Thekdi, A.; Sciote, J.J. Anatomy and fiber type composition of human interarytenoid muscle. Ann. Otol. Rhinol. Laryngol. 2004, 113, 97–107. [Google Scholar] [CrossRef]
  3. Burke, R.E.; Levine, D.N.; Zajac, F.E., 3rd. Mammalian motor units: Physiological-histochemical correlation in three types in cat gastrocnemius. Science 1971, 174, 709–712. [Google Scholar] [CrossRef]
  4. Brooke, M.H.; Kaiser, K.K. Muscle fiber types: How many and what kind? Arch. Neurol. 1970, 23, 369–379. [Google Scholar] [CrossRef]
  5. Schiaffino, S.; Reggiani, C. Fiber types in mammalian skeletal muscles. Physiol. Rev. 2011, 91, 1447–1531. [Google Scholar] [CrossRef]
  6. Larsson, L.; Edström, L.; Lindegren, B.; Gorza, L.; Schiaffino, S. MHC composition and enzyme-histochemical and physiological properties of a novel fast-twitch motor unit type. Am. J. Physiol. 1991, 261, C93–C101. [Google Scholar] [CrossRef]
  7. Barclay, C.J.; Constable, J.K.; Gibbs, C.L. Energetics of fast- and slow-twitch muscles of the mouse. J. Physiol. 1993, 472, 61–80. [Google Scholar] [CrossRef]
  8. He, Z.-H.; Bottinelli, R.; Pellegrino, M.A.; Ferenczi, M.A.; Reggiani, C. ATP Consumption and Efficiency of Human Single Muscle Fibers with Different Myosin Isoform Composition. Biophys. J. 2000, 79, 945–961. [Google Scholar] [CrossRef]
  9. Zierath, J.R.; Hawley, J.A. Skeletal muscle fiber type: Influence on contractile and metabolic properties. PLoS Biol. 2004, 2, e348. [Google Scholar] [CrossRef]
  10. Baker, J.S.; McCormick, M.C.; Robergs, R.A. Interaction among Skeletal Muscle Metabolic Energy Systems during Intense Exercise. J. Nutr. Metab. 2010, 2010, 905612. [Google Scholar] [CrossRef]
  11. Lievens, E.; Klass, M.; Bex, T.; Derave, W. Muscle fiber typology substantially influences time to recover from high-intensity exercise. J. Appl. Physiol. 2020, 128, 648–659. [Google Scholar] [CrossRef]
  12. Plotkin, D.L.; Roberts, M.D.; Haun, C.T.; Schoenfeld, B.J. Muscle Fiber Type Transitions with Exercise Training: Shifting Perspectives. Sports 2021, 9, 127. [Google Scholar] [CrossRef]
  13. Stozer, A.; Vodopivc, P.; Krizancic Bombek, L. Pathophysiology of exercise-induced muscle damage and its structural, functional, metabolic, and clinical consequences. Physiol. Res. 2020, 69, 565–598. [Google Scholar] [CrossRef]
  14. Proske, U.; Morgan, D.L. Muscle damage from eccentric exercise: Mechanism, mechanical signs, adaptation and clinical applications. J. Physiol. 2001, 537, 333–345. [Google Scholar] [CrossRef]
  15. Tu, H.; Li, Y.L. Inflammation balance in skeletal muscle damage and repair. Front. Immunol. 2023, 14, 1133355. [Google Scholar] [CrossRef]
  16. Furrer, R.; Handschin, C. Optimized Engagement of Macrophages and Satellite Cells in the Repair and Regeneration of Exercised Muscle. In Hormones, Metabolism and the Benefits of Exercise; Spiegelman, B., Ed.; Springer: Cham, Switzerland, 2017; pp. 57–66. [Google Scholar]
  17. Su, Y.; Su, Z. Impact of exercise on immune cell infiltration in muscle tissue: Implications for muscle repair and chronic disease. Clin. Exp. Med. 2025, 25, 306. [Google Scholar] [CrossRef]
  18. Hody, S.; Croisier, J.L.; Bury, T.; Rogister, B.; Leprince, P. Eccentric Muscle Contractions: Risks and Benefits. Front. Physiol. 2019, 10, 536. [Google Scholar] [CrossRef]
  19. Mauro, A. Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 1961, 9, 493–495. [Google Scholar] [CrossRef]
  20. Verdijk, L.B.; Snijders, T.; Drost, M.; Delhaas, T.; Kadi, F.; van Loon, L.J. Satellite cells in human skeletal muscle; from birth to old age. Age 2014, 36, 545–547. [Google Scholar] [CrossRef]
  21. Almeida, C.F.; Fernandes, S.A.; Ribeiro Junior, A.F.; Keith Okamoto, O.; Vainzof, M. Muscle Satellite Cells: Exploring the Basic Biology to Rule Them. Stem Cells Int. 2016, 2016, 1078686. [Google Scholar] [CrossRef]
  22. Feige, P.; Brun, C.E.; Ritso, M.; Rudnicki, M.A. Orienting Muscle Stem Cells for Regeneration in Homeostasis, Aging, and Disease. Cell Stem Cell 2018, 23, 653–664. [Google Scholar] [CrossRef]
  23. Dewi, L.; Lin, Y.C.; Nicholls, A.; Condello, G.; Huang, C.Y.; Kuo, C.H. Pax7+ Satellite Cells in Human Skeletal Muscle After Exercise: A Systematic Review and Meta-analysis. Sports Med. 2023, 53, 457–480. [Google Scholar] [CrossRef]
  24. Pugh, J.K.; Faulkner, S.H.; Turner, M.C.; Nimmo, M.A. Satellite cell response to concurrent resistance exercise and high-intensity interval training in sedentary, overweight/obese, middle-aged individuals. Eur. J. Appl. Physiol. 2018, 118, 225–238. [Google Scholar] [CrossRef]
  25. Mackey, A.L.; Andersen, L.L.; Frandsen, U.; Sjøgaard, G. Strength training increases the size of the satellite cell pool in type I and II fibres of chronically painful trapezius muscle in females. J. Physiol. 2011, 589, 5503–5515. [Google Scholar] [CrossRef]
  26. Treede, R.D.; Rief, W.; Barke, A.; Aziz, Q.; Bennett, M.I.; Benoliel, R.; Cohen, M.; Evers, S.; Finnerup, N.B.; First, M.B.; et al. A classification of chronic pain for ICD-11. Pain 2015, 156, 1003–1007. [Google Scholar] [CrossRef]
  27. Cieza, A.; Causey, K.; Kamenov, K.; Hanson, S.W.; Chatterji, S.; Vos, T. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2021, 396, 2006–2017, Erratum in Lancet 2021, 397, 198. [Google Scholar] [CrossRef]
  28. Liu, M.; Rong, J.; An, X.; Li, Y.; Min, Y.; Yuan, G.; Yang, Y.; Li, M. Global, regional, and national burden of musculoskeletal disorders, 1990–2021: An analysis of the global burden of disease study 2021 and forecast to 2035. Front. Public Health 2025, 13, 1562701. [Google Scholar] [CrossRef]
  29. Prego-Domínguez, J.; Khazaeipour, Z.; Mallah, N.; Takkouche, B. Socioeconomic status and occurrence of chronic pain: A meta-analysis. Rheumatology 2021, 60, 1091–1105. [Google Scholar] [CrossRef]
  30. James, J.J.; Mellow, M.L.; Bueckers, E.P.; Gutsch, S.B.; Wrucke, D.J.; Pearson, A.G.; Smith, A.E.; Hunter, S.K. Sex differences in human skeletal muscle fiber types and the influence of age, physical activity, and muscle group: A systematic review and meta-analysis. Physiol. Rep. 2025, 13, e70616. [Google Scholar] [CrossRef]
  31. Eason, J.M.; Schwartz, G.A.; Pavlath, G.K.; English, A.W. Sexually dimorphic expression of myosin heavy chains in the adult mouse masseter. J. Appl. Physiol. 2000, 89, 251–258. [Google Scholar] [CrossRef]
  32. Larsson, B.; Björk, J.; Elert, J.; Lindman, R.; Gerdle, B. Fibre type proportion and fibre size in trapezius muscle biopsies from cleaners with and without myalgia and its correlation with ragged red fibres, cytochrome-c-oxidase-negative fibres, biomechanical output, perception of fatigue, and surface electromyography during repetitive forward flexions. Eur. J. Appl. Physiol. 2001, 84, 492–502. [Google Scholar] [PubMed]
  33. Henneman, E.; Olson, C.B. Relations between structure and function in the design of skeletal muscles. J. Neurophysiol. 1965, 28, 581–598. [Google Scholar] [CrossRef]
  34. Sterling, M.; Jull, G.; Wright, A. The effect of musculoskeletal pain on motor activity and control. J. Pain 2001, 2, 135–145. [Google Scholar] [CrossRef]
  35. Thorn, S.; Forsman, M.; Zhang, Q.; Taoda, K. Low-threshold motor unit activity during a 1-h static contraction in the trapezius muscle. Int. J. Ind. Ergon. 2002, 30, 225–236. [Google Scholar] [CrossRef]
  36. Andersen, L.L.; Suetta, C.; Andersen, J.L.; Kjær, M.; Sjøgaard, G. Increased proportion of megafibers in chronically painful muscles. Pain 2008, 139, 588–593. [Google Scholar] [CrossRef]
  37. Mesquita, R.N.O.; Skarabot, J.; Pearcey, G.E.P. Low-threshold motor units can be a pain during experimental muscle pain. J. Physiol. 2020, 598, 2545–2547. [Google Scholar] [CrossRef]
  38. Carmona, G.; Guerrero, M.; Cussó, R.; Padullés, J.M.; Moras, G.; Lloret, M.; Bedini, J.L.; Cadefau, J.A. Muscle enzyme and fiber type-specific sarcomere protein increases in serum after inertial concentric-eccentric exercise. Scand. J. Med. Sci. Sports 2015, 25, e547–e557. [Google Scholar] [CrossRef]
  39. Ureczky, D.; Vácz, G.; Costa, A.; Kopper, B.; Lacza, Z.; Hortobágyi, T.; Tihanyi, J. The effects of short-term exercise training on peak-torque are time- and fiber-type dependent. J. Strength Cond. Res. 2014, 28, 2204–2213. [Google Scholar] [CrossRef] [PubMed]
  40. Guerrero, M.; Guiu-Comadevall, M.; Cadefau, J.A.; Parra, J.; Balius, R.; Estruch, A.; Rodas, G.; Bedini, J.L.; Cusso, R. Fast and slow myosins as markers of muscle injury. Br. J. Sports Med. 2008, 42, 581–584. [Google Scholar] [CrossRef]
  41. Bogdanis, G.C.; Tsoukos, A.; Brown, L.E.; Selima, E.; Veligekas, P.; Spengos, K.; Terzis, G. Muscle Fiber and Performance Changes after Fast Eccentric Complex Training. Med. Sci. Sports Exerc. 2018, 50, 729–738. [Google Scholar] [CrossRef]
  42. Fullen, B.M.; Wittink, H.; De Groef, A.; Hoegh, M.; McVeigh, J.G.; Martin, D.; Smart, K. Musculoskeletal Pain: Current and Future Directions of Physical Therapy Practice. Arch. Rehabil. Res. Clin. Transl. 2023, 5, 100258. [Google Scholar] [CrossRef]
  43. Behringer, C.; Nagib, N.; Nagib, N. Introduction to multimodal musculoskeletal treatment models: A viewpoint. Discov. Appl. Sci. 2025, 7, 820. [Google Scholar] [CrossRef]
  44. Dawod, M.S.; Alswerki, M.N.; Alelaumi, A.F.; Alshloul, S.A.; Husami, M.Y.; Sulaiman, S.G.; Al-Azzawi, M.T.; Al-Rawashdah, S.F.; Abualhaj, S. Approach to Adult Patients with Musculoskeletal Complaints and Normal Findings: A Guide for Clinical Practice. Orthop. Res. Rev. 2025, 17, 503–516. [Google Scholar] [CrossRef]
  45. Mackey, A.L.; Andersen, L.L.; Frandsen, U.; Suetta, C.; Sjøgaard, G. Distribution of myogenic progenitor cells and myonuclei is altered in women with vs. those without chronically painful trapezius muscle. J. Appl. Physiol. 2010, 109, 1920–1929. [Google Scholar] [CrossRef]
  46. Kadi, F.; Ahlgren, C.; Waling, K.; Sundelin, G.; Thornell, L.E. The effects of different training programs on the trapezius muscle of women with work-related neck and shoulder myalgia. Acta Neuropathol. 2000, 100, 253–258. [Google Scholar] [CrossRef]
  47. Lindman, R.; Hagberg, M.; Angqvist, K.A.; Söderlund, K.; Hultman, E.; Thornell, L.E. Changes in muscle morphology in chronic trapezius myalgia. Scand J. Work. Environ. Health 1991, 17, 347–355. [Google Scholar] [CrossRef]
  48. Kadi, F.; Hägg, G.; Håkansson, R.; Holmner, S.; Butler-Browne, G.S.; Thornell, L.E. Structural changes in male trapezius muscle with work-related myalgia. Acta Neuropathol. 1998, 95, 352–360. [Google Scholar] [CrossRef]
  49. De Meulemeester, K.; Calders, P.; Van Dorpe, J.; De Pauw, R.; Petrovic, M.; Cagnie, B. Morphological Differences in the Upper Trapezius Muscle Between Female Office Workers With and Without Trapezius Myalgia: Facts or Fiction?: A Cross-Sectional Study. Am. J. Phys. Med. Rehabil. 2019, 98, 117–124. [Google Scholar] [CrossRef]
  50. Weber, B.R.; Uhlig, Y.; Grob, D.; Dvorák, J.; Müntener, M. Duration of pain and muscular adaptations in patients with dysfunction of the cervical spine. J. Orthop. Res. 1993, 11, 805–810. [Google Scholar] [CrossRef] [PubMed]
  51. Mazis, N.; Papachristou, D.J.; Zouboulis, P.; Tyllianakis, M.; Scopa, C.D.; Megas, P. The effect of different physical activity levels on muscle fiber size and type distribution of lumbar multifidus. A biopsy study on low back pain patient groups and healthy control subjects. Eur. J. Phys. Rehabil. Med. 2009, 45, 459–467. [Google Scholar] [PubMed]
  52. Purushotham, S.; Hodson, N.; Greig, C.; Gardner, A.; Falla, D. Microscopic changes in the multifidus muscle in people with low back pain associated with lumbar disc herniation. Sci. Rep. 2024, 14, 31927. [Google Scholar] [CrossRef]
  53. Mannion, A.F.; Weber, B.R.; Dvorak, J.; Grob, D.; Müntener, M. Fibre type characteristics of the lumbar paraspinal muscles in normal healthy subjects and in patients with low back pain. J. Orthop. Res. 1997, 15, 881–887. [Google Scholar] [CrossRef]
  54. Agten, A.; Stevens, S.; Verbrugghe, J.; Timmermans, A.; Vandenabeele, F. Biopsy samples from the erector spinae of persons with nonspecific chronic low back pain display a decrease in glycolytic muscle fibers. Spine J. 2020, 20, 199–206. [Google Scholar] [CrossRef] [PubMed]
  55. Mannion, A.F.; Käser, L.; Weber, E.; Rhyner, A.; Dvorak, J.; Müntener, M. Influence of age and duration of symptoms on fibre type distribution and size of the back muscles in chronic low back pain patients. Eur. Spine J. 2000, 9, 273–281. [Google Scholar] [CrossRef]
  56. Padwal, J.; Berry, D.B.; Hubbard, J.C.; Zlomislic, V.; Allen, R.T.; Garfin, S.R.; Ward, S.R.; Shahidi, B. Regional differences between superficial and deep lumbar multifidus in patients with chronic lumbar spine pathology. BMC Musculoskelet. Disord. 2020, 21, 764. [Google Scholar] [CrossRef]
  57. Srikuea, R.; Symons, T.B.; Long, D.E.; Lee, J.D.; Shang, Y.; Chomentowski, P.J.; Yu, G.; Crofford, L.J.; Peterson, C.A. Association of fibromyalgia with altered skeletal muscle characteristics which may contribute to postexertional fatigue in postmenopausal women. Arthritis Rheum. 2013, 65, 519–528. [Google Scholar] [CrossRef] [PubMed]
  58. Sobreira, C.; Marques, W., Jr.; Barreira, A.A. Myalgia as the revealing symptom of multicore disease and fibre type disproportion myopathy. J. Neurol. Neurosurg. Psychiatry 2003, 74, 1317–1319. [Google Scholar] [CrossRef][Green Version]
  59. Putzu, G.A.; Figarella-Branger, D.; Baeta, A.M.; Lepidi, H.; Pellissier, J.F. Acquired multifocal myofibrillar disruption selective of type II fibres. Neuropathol. Appl. Neurobiol. 1996, 22, 38–43. [Google Scholar] [CrossRef]
  60. Dickx, N.; Cagnie, B.; Achten, E.; Vandemaele, P.; Parlevliet, T.; Danneels, L. Differentiation between deep and superficial fibers of the lumbar multifidus by magnetic resonance imaging. Eur. Spine J. 2010, 19, 122–128. [Google Scholar] [CrossRef][Green Version]
  61. Crossman, K.; Mahon, M.; Watson, P.J.; Oldham, J.A.; Cooper, R.G. Chronic low back pain-associated paraspinal muscle dysfunction is not the result of a constitutionally determined “adverse” fiber-type composition. Spine 2004, 29, 628–634. [Google Scholar] [CrossRef]
  62. Broos, S.; Malisoux, L.; Theisen, D.; Van Thienen, R.; Francaux, M.; Thomis, M.A.; Deldicque, L. The stiffness response of type IIa fibres after eccentric exercise-induced muscle damage is dependent on ACTN3 r577X polymorphism. Eur. J. Sport Sci. 2019, 19, 480–489. [Google Scholar] [CrossRef]
  63. Vincent, B.; Windelinckx, A.; Nielens, H.; Ramaekers, M.; Van Leemputte, M.; Hespel, P.; Thomis, M.A. Protective role of alpha-actinin-3 in the response to an acute eccentric exercise bout. J. Appl. Physiol. 2010, 109, 564–573. [Google Scholar] [CrossRef]
  64. Chen, T.C. Effects of a second bout of maximal eccentric exercise on muscle damage and electromyographic activity. Eur. J. Appl. Physiol. 2003, 89, 115–121. [Google Scholar] [CrossRef]
  65. Mair, J.; Mayr, M.; Müller, E.; Koller, A.; Haid, C.; Artner-Dworzak, E.; Calzolari, C.; Larue, C.; Puschendorf, B. Rapid adaptation to eccentric exercise-induced muscle damage. Int. J. Sports Med. 1995, 16, 352–356. [Google Scholar] [CrossRef]
  66. Morton, R.W.; Sonne, M.W.; Farias Zuniga, A.; Mohammad, I.Y.Z.; Jones, A.; McGlory, C.; Keir, P.J.; Potvin, J.R.; Phillips, S.M. Muscle fibre activation is unaffected by load and repetition duration when resistance exercise is performed to task failure. J. Physiol. 2019, 597, 4601–4613. [Google Scholar] [CrossRef]
  67. Zhao, W.P.; Kawaguchi, Y.; Matsui, H.; Kanamori, M.; Kimura, T. Histochemistry and morphology of the multifidus muscle in lumbar disc herniation: Comparative study between diseased and normal sides. Spine 2000, 25, 2191–2199. [Google Scholar] [CrossRef] [PubMed]
  68. Ge, H.-Y.; Arendt-Nielsen, L.; Farina, D.; Madeleine, P. Gender-specific differences in electromyographic changes and perceived pain induced by experimental muscle pain during sustained contractions of the upper trapezius muscle. Muscle Nerve 2005, 32, 726–733. [Google Scholar] [CrossRef] [PubMed]
  69. Esbjornsson, M.E.; Dahlstrom, M.S.; Gierup, J.W.; Jansson, E.C. Muscle fiber size in healthy children and adults in relation to sex and fiber types. Muscle Nerve 2021, 63, 586–592. [Google Scholar] [CrossRef]
  70. Agten, A.; Verbrugghe, J.; Stevens, S.; Eijnde, B.O.; Timmermans, A.; Vandenabeele, F. High Intensity Training Increases Muscle Area Occupied by Type II Muscle Fibers of the Multifidus Muscle in Persons with Non-Specific Chronic Low Back Pain: A Pilot Trial. Appl. Sci. 2021, 11, 3306. [Google Scholar] [CrossRef]
  71. Verdijk, L.B.; Koopman, R.; Schaart, G.; Meijer, K.; Savelberg, H.H.; van Loon, L.J. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. Am. J. Physiol. Endocrinol. Metab. 2007, 292, E151–E157. [Google Scholar] [CrossRef]
  72. Mao, X.; Lv, K.; Qi, W.; Cheng, W.; Li, T.; Sun, Y.; Jin, H.; Pan, H.; Wang, D. Research progress on sarcopenia in the musculoskeletal system. Bone Res. 2025, 13, 78. [Google Scholar] [CrossRef] [PubMed]
  73. Larsson, L.; Degens, H.; Li, M.; Salviati, L.; Lee, Y.I.; Thompson, W.; Kirkland, J.L.; Sandri, M. Sarcopenia: Aging-Related Loss of Muscle Mass and Function. Physiol. Rev. 2019, 99, 427–511. [Google Scholar] [CrossRef] [PubMed]
  74. Horlem, T.; Carvalhal, S.R.S.; Bonatto, S.J.R.; Fernandes, L.C. Molecular Framework of the Onset and Progression of Skeletal Muscle Aging. Int. J. Mol. Sci. 2025, 26, 10145. [Google Scholar] [CrossRef]
  75. Walton, R.G.; Kosmac, K.; Mula, J.; Fry, C.S.; Peck, B.D.; Groshong, J.S.; Finlin, B.S.; Zhu, B.; Kern, P.A.; Peterson, C.A. Human skeletal muscle macrophages increase following cycle training and are associated with adaptations that may facilitate growth. Sci. Rep. 2019, 9, 969. [Google Scholar] [CrossRef]
  76. Saito, Y.; Chikenji, T.S.; Matsumura, T.; Nakano, M.; Fujimiya, M. Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors. Nat. Commun. 2020, 11, 889. [Google Scholar] [CrossRef]
  77. Murach, K.A.; Fry, C.S.; Kirby, T.J.; Jackson, J.R.; Lee, J.D.; White, S.H.; Dupont-Versteegden, E.E.; McCarthy, J.J.; Peterson, C.A. Starring or Supporting Role? Satellite Cells and Skeletal Muscle Fiber Size Regulation. Physiology 2018, 33, 26–38. [Google Scholar] [CrossRef]
  78. Bagley, J.R.; Denes, L.T.; McCarthy, J.J.; Wang, E.T.; Murach, K.A. The myonuclear domain in adult skeletal muscle fibres: Past, present and future. J. Physiol. 2023, 601, 723–741. [Google Scholar] [CrossRef]
  79. Minerbi, A.; Vulfsons, S. Challenging the Cinderella Hypothesis: A New Model for the Role of the Motor Unit Recruitment Pattern in the Pathogenesis of Myofascial Pain Syndrome in Postural Muscles. Rambam Maimonides Med. J. 2018, 9, e0021-8. [Google Scholar] [CrossRef] [PubMed]
  80. Steen, J.P.; Jaiswal, K.S.; Kumbhare, D. Myofascial Pain Syndrome: An Update on Clinical Characteristics, Etiopathogenesis, Diagnosis, and Treatment. Muscle Nerve 2025, 71, 889–910. [Google Scholar] [CrossRef]
  81. Warwick, C.A.; Keyes, A.L.; Woodruff, T.M.; Usachev, Y.M. The complement cascade in the regulation of neuroinflammation, nociceptive sensitization, and pain. J. Biol. Chem. 2021, 297, 101085. [Google Scholar] [CrossRef] [PubMed]
  82. Barnig, C.; Lutzweiler, G.; Giannini, M.; Lejay, A.; Charles, A.L.; Meyer, A.; Geny, B. Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins. Antioxidants 2022, 11, 1213. [Google Scholar] [CrossRef]
  83. Ross, J.L.; Queme, L.F.; Shank, A.T.; Hudgins, R.C.; Jankowski, M.P. Sensitization of group III and IV muscle afferents in the mouse after ischemia and reperfusion injury. J. Pain 2014, 15, 1257–1270. [Google Scholar] [CrossRef] [PubMed]
  84. Gordon, T. Neuromuscular Activity Determines, at Least in Part, the Motoneuron, Nerve and Muscle Properties Under Normal Conditions and After Nerve Injury. Int. J. Mol. Sci. 2025, 26, 6891. [Google Scholar] [CrossRef] [PubMed]
  85. Murray, G.M.; Sessle, B.J. Pain-sensorimotor interactions: New perspectives and a new model. Neurobiol. Pain 2024, 15, 100150. [Google Scholar] [CrossRef]
  86. Mastaglia, F.L. The relationship between muscle pain and fatigue. Neuromuscul. Disord. 2012, 22, S178–S180. [Google Scholar] [CrossRef]
  87. Nardone, A.; Schieppati, M. Shift of activity from slow to fast muscle during voluntary lengthening contractions of the triceps surae muscles in humans. J. Physiol. 1988, 395, 363–381. [Google Scholar] [CrossRef]
  88. Bai, Z.; Zhang, D.; Liang, D.; Chen, X.; Shi, X.; Chen, S. Effect of Eccentric Training with Different Durations, Intensities, and Contraction Velocities on Upper Limb Muscle Strength: A Meta-Analysis. Life 2025, 15, 456. [Google Scholar] [CrossRef]
  89. Mannion, A.F.; Taimela, S.; Muntener, M.; Dvorak, J. Active therapy for chronic low back pain part 1. Effects on back muscle activation, fatigability, and strength. Spine 2001, 26, 897–908. [Google Scholar] [CrossRef]
  90. Wyckelsma, V.L.; Venckunas, T.; Houweling, P.J.; Schlittler, M.; Lauschke, V.M.; Tiong, C.F.; Wood, H.D.; Ivarsson, N.; Paulauskas, H.; Eimantas, N.; et al. Loss of α-actinin-3 during human evolution provides superior cold resilience and muscle heat generation. Am. J. Hum. Genet. 2021, 108, 446–457. [Google Scholar] [CrossRef] [PubMed]
  91. Seto, J.T.; Chan, S.; Turner, N.; MacArthur, D.G.; Raftery, J.M.; Berman, Y.D.; Quinlan, K.G.; Cooney, G.J.; Head, S.; Yang, N.; et al. The effect of alpha-actinin-3 deficiency on muscle aging. Exp. Gerontol. 2011, 46, 292–302. [Google Scholar] [CrossRef]
  92. Houweling, P.J.; Papadimitriou, I.D.; Seto, J.T.; Perez, L.M.; Coso, J.D.; North, K.N.; Lucia, A.; Eynon, N. Is evolutionary loss our gain? The role of ACTN3 p.Arg577Ter (R577X) genotype in athletic performance, ageing, and disease. Hum. Mutat. 2018, 39, 1774–1787. [Google Scholar] [CrossRef]
  93. Lee, F.X.; Houweling, P.J.; North, K.N.; Quinlan, K.G. How does α-actinin-3 deficiency alter muscle function? Mechanistic insights into ACTN3, the ‘gene for speed’. Biochim. Biophys. Acta 2016, 1863, 686–693. [Google Scholar] [CrossRef]
  94. Lexell, J.; Downham, D. What is the effect of ageing on type 2 muscle fibres? J. Neurol. Sci. 1992, 107, 250–251. [Google Scholar] [CrossRef]
  95. van Wessel, T.; de Haan, A.; van der Laarse, W.J.; Jaspers, R.T. The muscle fiber type-fiber size paradox: Hypertrophy or oxidative metabolism? Eur. J. Appl. Physiol. 2010, 110, 665–694. [Google Scholar] [CrossRef] [PubMed]
  96. Agten, A.; Stevens, S.; Verbrugghe, J.; Eijnde, B.O.; Timmermans, A.; Vandenabeele, F. The lumbar multifidus is characterised by larger type I muscle fibres compared to the erector spinae. Anat. Cell Biol. 2020, 53, 143–150. [Google Scholar] [CrossRef] [PubMed]
  97. Breen, E.; Tang, K.; Olfert, M.; Knapp, A.; Wagner, P. Skeletal muscle capillarity during hypoxia: VEGF and its activation. High Alt. Med. Biol. 2008, 9, 158–166. [Google Scholar] [CrossRef] [PubMed]
  98. Purushotham, S.; Stephenson, R.S.; Sanderson, A.; Abichandani, D.; Greig, C.; Gardner, A.; Falla, D. Microscopic changes in the spinal extensor musculature in people with chronic spinal pain: A systematic review. Spine J. 2022, 22, 1205–1221. [Google Scholar] [CrossRef]
  99. Hodges, P.W.; Tucker, K. Moving differently in pain: A new theory to explain the adaptation to pain. Pain 2011, 152, S90–S98. [Google Scholar] [CrossRef]
  100. Zhang, S.; Wang, Y.; Li, T.; Ma, J.; He, R.; Han, X.; Wu, W.; Wang, C. Relation Between Abnormal Spontaneous Brain Activity and Altered Neuromuscular Activation of Lumbar Paraspinal Muscles in Chronic Low Back Pain. Arch. Phys. Med. Rehabil. 2024, 105, 2107–2117. [Google Scholar] [CrossRef]
  101. Hides, J.A.; Richardson, C.A.; Jull, G.A. Multifidus muscle recovery is not automatic after resolution of acute, first-episode low back pain. Spine 1996, 21, 2763–2769. [Google Scholar] [CrossRef]
  102. Newcomer, K.L.; Jacobson, T.D.; Gabriel, D.A.; Larson, D.R.; Brey, R.H.; An, K.N. Muscle activation patterns in subjects with and without low back pain. Arch. Phys. Med. Rehabil. 2002, 83, 816–821. [Google Scholar] [CrossRef]
  103. Zhu, X.Z.; Parnianpour, M.; Nordin, M.; Kahanovitz, N. Histochemistry and morphology of erector spinae muscle in lumbar disc herniation. Spine 1989, 14, 391–397. [Google Scholar] [CrossRef]
  104. Rui, Y.; Bai, J.; Perrimon, N. Sarcomere formation occurs by the assembly of multiple latent protein complexes. PLoS Genet. 2010, 6, e1001208. [Google Scholar] [CrossRef]
  105. Maroni, C.R.; Friedman, M.A.; Zhang, Y.; McClure, M.J.; Fulle, S.; Farber, C.R.; Donahue, H.J. Genetic variability affects the response of skeletal muscle to disuse. J. Musculoskelet. Neuronal Interact. 2021, 21, 387–396. [Google Scholar]
  106. Leońska-Duniec, A. Genetic Susceptibility to Sport-Related Muscle Injuries: Insights from the Literature and Novel Gene Candidates. Int. J. Mol. Sci. 2025, 26, 11175. [Google Scholar] [CrossRef] [PubMed]
  107. Marques, I.S.; Tavares, V.; Vieira Neto, B.; Lopes, L.R.; Goes, R.A.; Guimarães, J.A.M.; Perini, J.A.; Medeiros, R. Genetic Variations in Susceptibility to Traumatic Muscle Injuries and Muscle Pain among Brazilian High-Performance Athletes. Int. J. Mol. Sci. 2024, 25, 3300. [Google Scholar] [CrossRef] [PubMed]
  108. Ruggiero, L.; Manganelli, F.; Santoro, L. Muscle pain syndromes and fibromyalgia: The role of muscle biopsy. Curr. Opin. Support. Palliat. Care 2018, 12, 382–387. [Google Scholar] [CrossRef]
  109. Carneiro, B.D.; Torres, S.; Costa-Pereira, J.T.; Pozza, D.H.; Tavares, I. Descending Pain Modulation in Fibromyalgia: A Short Review of Mechanisms and Biomarkers. Diagnostics 2025, 15, 2702. [Google Scholar] [CrossRef] [PubMed]
  110. Chakraborty, S.; Ben-David, R.; Shemer, S. Combating muscle atrophy: Emerging therapeutic targets that are fiber-type-specific. FEBS J. 2025, 292, 6481–6496. [Google Scholar] [CrossRef]
  111. Booth, F.W.; Roberts, C.K.; Laye, M.J. Lack of exercise is a major cause of chronic diseases. Compr. Physiol. 2012, 2, 1143–1211. [Google Scholar] [CrossRef]
  112. Hall, E.C.R.; Semenova, E.A.; Bondareva, E.A.; Borisov, O.V.; Andryushchenko, O.N.; Andryushchenko, L.B.; Zmijewski, P.; Generozov, E.V.; Ahmetov, I.I. Association of muscle fiber composition with health and exercise-related traits in athletes and untrained subjects. Biol. Sport 2021, 38, 659–666. [Google Scholar] [CrossRef] [PubMed]
  113. Carroll, K.M.; Bazyler, C.D.; Bernards, J.R.; Taber, C.B.; Stuart, C.A.; DeWeese, B.H.; Sato, K.; Stone, M.H. Skeletal Muscle Fiber Adaptations Following Resistance Training Using Repetition Maximums or Relative Intensity. Sports 2019, 7, 169. [Google Scholar] [CrossRef]
  114. Chen, J.; Han, B.; Wu, C. On the superiority of a combination of aerobic and resistance exercise for fibromyalgia syndrome: A network meta-analysis. Front. Psychol. 2022, 13, 949256. [Google Scholar] [CrossRef] [PubMed]
  115. Smith, J.A.B.; Murach, K.A.; Dyar, K.A.; Zierath, J.R. Exercise metabolism and adaptation in skeletal muscle. Nat. Rev. Mol. Cell Biol. 2023, 24, 607–632. [Google Scholar] [CrossRef]
  116. Rodriguez-Dominguez, A.J.; Rebollo-Salas, M.; Chillon-Martinez, R.; Rosales-Tristancho, A.; Villa-Del-Pino, I.; Jimenez-Rejano, J.J. The most effective therapeutic exercises for pain intensity in women with fibromyalgia: A systematic review and network meta-analysis. Braz. J. Phys. Ther. 2025, 29, 101226. [Google Scholar] [CrossRef]
  117. Liu, C.J.; Latham, N.K. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst. Rev. 2009, 2009, CD002759. [Google Scholar] [CrossRef] [PubMed]
  118. Weakley, J.; Schoenfeld, B.J.; Ljungberg, J.; Halson, S.L.; Phillips, S.M. Physiological Responses and Adaptations to Lower Load Resistance Training: Implications for Health and Performance. Sports Med.-Open 2023, 9, 28. [Google Scholar] [CrossRef]
  119. Moro, T.; Brightwell, C.R.; Volpi, E.; Rasmussen, B.B.; Fry, C.S. Resistance exercise training promotes fiber type-specific myonuclear adaptations in older adults. J. Appl. Physiol. 2020, 128, 795–804. [Google Scholar] [CrossRef]
  120. Molmen, K.S.; Almquist, N.W.; Skattebo, O. Effects of Exercise Training on Mitochondrial and Capillary Growth in Human Skeletal Muscle: A Systematic Review and Meta-Regression. Sports Med. 2025, 55, 115–144. [Google Scholar] [CrossRef]
  121. Ding, Y.; Wan, Q.; Kim, J.C.; Liu, W.; Ji, W. The role of exercise induced capillarization adaptations in skeletal muscle aging: A systematic review. Front. Physiol. 2025, 16, 1681184. [Google Scholar] [CrossRef]
  122. Baroncini, A.; Maffulli, N.; Manocchio, N.; Bossa, M.; Foti, C.; Schäfer, L.; Klimuch, A.; Migliorini, F. Active and passive physical therapy in patients with chronic low-back pain: A level I Bayesian network meta-analysis. J. Orthop. Traumatol. 2025, 26, 66. [Google Scholar] [CrossRef]
  123. De la Corte-Rodriguez, H.; Roman-Belmonte, J.M.; Resino-Luis, C.; Madrid-Gonzalez, J.; Rodriguez-Merchan, E.C. The Role of Physical Exercise in Chronic Musculoskeletal Pain: Best Medicine-A Narrative Review. Healthcare 2024, 12, 242. [Google Scholar] [CrossRef]
  124. Choi, H.K.; Gwon, H.J.; Kim, S.R.; Park, C.S.; Cho, B.J. Effects of active rehabilitation therapy on muscular back strength and subjective pain degree in chronic lower back pain patients. J. Phys. Ther. Sci. 2016, 28, 2700–2702. [Google Scholar] [CrossRef]
  125. Kerbaul, F.; Brousse, M.; Collart, F.; Pellissier, J.F.; Planche, D.; Fernandez, C.; Gouin, F.; Guidon, C. Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes. Crit. Care 2004, 8, R358–R366. [Google Scholar] [CrossRef] [PubMed]
  126. Imrani, L.; Boudaoud, S.; Lahaye, C.; Moreau, C.; Ghezal, M.; Ben Manaa, S.; Doulazmi, M.; Laforet, J.; Marin, F.; Kinugawa, K. High-density Surface Electromyography as Biomarker of Muscle Aging. J. Gerontol. A Biol. Sci. Med. Sci. 2023, 78, 25–33. [Google Scholar] [CrossRef] [PubMed]
  127. Shandiz, E.; Gaskell, A.; Ingram, M.; Trajano, G.S.; Fernandes, G.L.; Henkin, J.S.; McCombe, P.A.; Henderson, R.D. Applying high-density surface EMG to the study of neuromuscular disorders: A systematic review. Clin. Neurophysiol. 2025, 179, 2110983. [Google Scholar] [CrossRef] [PubMed]
  128. Chen, Z.J.; Huang, X.L.; Xia, N.; Gu, M.H.; Xu, J.; Lu, M.; Chen, H.; Xiong, C.H.; Chen, Y. Next-Generation Neurotechnologies Inspired by Motor Primitive Model for Restoring Human Natural Movement. Research 2025, 8, 0942. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Overview of skeletal muscle fibers. Parts of this figure were drawn using pictures from Servier Medical Art by Servier (https://smart.servier.com, accessed on 5 January 2026), which is licensed under Attribution 4.0 International (Creative Commons CC BY 4.0).
Figure 1. Overview of skeletal muscle fibers. Parts of this figure were drawn using pictures from Servier Medical Art by Servier (https://smart.servier.com, accessed on 5 January 2026), which is licensed under Attribution 4.0 International (Creative Commons CC BY 4.0).
Biomedicines 14 00794 g001
Figure 2. Conceptual model: chronic muscle pain according to the type of muscle fiber. Parts of this figure were drawn using pictures from Servier Medical Art by Servier (https://smart.servier.com, accessed on 5 January 2026), which is licensed under Attribution 4.0 International (Creative Commons CC BY 4.0).
Figure 2. Conceptual model: chronic muscle pain according to the type of muscle fiber. Parts of this figure were drawn using pictures from Servier Medical Art by Servier (https://smart.servier.com, accessed on 5 January 2026), which is licensed under Attribution 4.0 International (Creative Commons CC BY 4.0).
Biomedicines 14 00794 g002
Table 1. Summary of relevant references concerning the relationship between muscle fiber types and muscle pain studies in humans.
Table 1. Summary of relevant references concerning the relationship between muscle fiber types and muscle pain studies in humans.
Reference/TypePopulationType of PainEvaluation MethodResults
[25]
Randomized controlled trial
42 women with trapezius myalgia: monotonous and repetitive work tasksChronic trapezius myalgiaImmunohistochemistryType I fibers: increase of 65% in satellite cells; Type II fibers: increase of 164% in satellite cells
[45]
Experimental, cross-sectional
62 female office workers: 42 with myalgia in trapezius muscle, with monotonous and repetitive work tasksChronic trapezius myalgiaFluorescent laminin stainingType I fibers contained more satellite cells than Type II fibers; Type II fibers, less frequently recruited during sustained low-intensity activity, had fewer satellite cells and showed smaller fiber areas indicative of atrophy
[46]
Randomized controlled trial
21 women with work-related neck and shoulder myalgia divided into three 10-week training programs Chronic Trapezius myalgiaEnzyme-immunohistochemical analysisStrength training increased Type IIA area (+49%) and proportion Coordination decreased Type I area; there was also an increased capillarization in Type I and IIA
[47]
Case–control
10 female patients with chronic trapezius myalgia due static and repetitive work tasks and 5 healthy femalesChronic Trapezius myalgiaEnzyme histochemical, immunohistochemical and biochemical analysesPatients had significantly larger Type I fibers and a lower capillary-to-fiber area ratio for Type I and Type IIA fibers
[36]
Case–control study
42 female workers with trapezius myalgia and 20 female matched workers withoutTrapezius myalgiaHistochemical Significantly higher proportion of Type I megafibers in females with trapezius myalgia and poor capillarization
[32]
Cross-sectional case–control study
25 female cleaners with trapezius myalgia and 25 without; 21 healthy female teachers without repetitive or static muscle workTrapezius myalgiaElectromyogram and ImmunohistochemistrySmaller cross-sectional area of Type II fibers in cleaners compared to teachers; no difference in Type I fibers
[48]
Case–control study
10 male forest machine operators with myalgia, 9 without myalgia, and 6 healthy controlsTrapezius myalgiaHistochemistry and immunohistochemistryMen with myalgia showed significant Type IIA fiber hypertrophy with a proportionally matched increase in capillarization showing an active injury-regeneration cycle
[49]
Cross-sectional study
17 female office workers with myalgia and 15 healthy controlsTrapezius myalgiaMajor histocompatibility complex immunohistochemistryHigher proportions of Type IIA and IIA/IIX fibers, and lower proportions of Type I fibers in the myalgia group
No differences in fiber size between groups, but Type I fibers were significantly larger than Type II fibers in both groups
[50]
Observational study
24 patients undergoing surgery for cervical dysfunction with severe neck painChronic neck painHistochemical methodsSymptom duration < 16 months showed higher proportion of transitional Type IIC fibers (active transformation)
Symptom duration > 20 months lacked Type IIC fibers
[51]
Cross-sectional case–control study
64 patients with low back pain,
17 healthy control individuals
Low back painHistochemicalLow back pain showed a higher Type II fiber proportion
The physical activity level did not influence fiber type and diameter
[52]
Observational study
30 healthy adults (11 men) undergoing microdiscectomy for lumbar disc herniationLow back pain Immunohistochemistry and epifluorescenceAffected multifidus contained a higher proportion of pathological fibers
Higher pain intensity and disability linked to smaller Type I fibers
[53]
Cross-sectional controlled study
21 low back pain patients and 21 healthy controlsLow back painHistochemicalPatients had more Type IIB than Type I fibers; early-stage (<1 year) pain was linked to higher Type IIC proportions, while long-term (>3 years) pain showed marked reduction
[54]
Cross sectional study
20 chronic low back pain and 18 healthy controlsLow back painImmunofluorescencePain is associated with fewer Type IIB fibers and a shift toward a more aerobic profile, with larger Type I and smaller Type IIB cross-sectional areas
[55]
Experimental study
59 patients (30 women) with chronic low back painChronic low back painHistochemical and
magnetic resonance
Type I: Longer symptoms, lower proportion; higher in pathological biopsies; Female > Male
Type IIA: Unaffected by symptom duration; diameter strongly tied to pain.
Type IIX: Longer symptoms, higher proportion + stronger glycolytic profile; diameter correlates with pain; Male > Female
Type IIC: Very low in chronic cases, Male > Female
[56]
Observational study
16 patients undergoing lumbar spinal surgery Chronic low back painHistochemical and MRINo significant differences in fiber type distribution, size, fat infiltration, or muscle degeneration between the superficial and deep multifidus
Chronic degeneration affects the multifidus globally
[57]
Experimental Study
37 healthy postmenopausal women with (n = 14) and without (n = 23) Fibromyalgia (FM)FM with a fatiguing exerciseHistochemistry, immunohistochemistry and electron microscopic FM patients show similar Type I/II proportions, but greater fiber-size variability, more small fibers, and lower capillary density
[58]
Case series
24-year-old man, 14-year-old male, and 47-year-old womenMyalgiaHistochemistry and immunohistochemistryType I fibers predominance with a selective uniform atrophy or a predominant multiple area of focal myofibrillar degeneration
[59]
Case series
10-year-old girl,
22-year-old man, and 55-year-old man
Myalgia and crampsElectromyogram, histochemistry, immunohistochemistry and electron microscopicAcquired multifocal myofibrillar disorganization selectively affects Type II muscle fibers
Legend: FM, fibromyalgia.
Table 2. Summary of relevant references concerning the relationship between muscle fiber types and muscle induced injury studies in humans.
Table 2. Summary of relevant references concerning the relationship between muscle fiber types and muscle induced injury studies in humans.
Reference/TypePopulationType Muscle InjuryEvaluation MethodResults
[60]
Cross-sectional experimental study
15 young malesExperimentally induced low back muscle pain with hypertonic saline solutionMagnetic resonanceDeep multifidus fibers are predominantly slow twitch compared to the superficial layer; no differential recruitment has been found following trunk extension with and without pain induction
[61]
Investigative case–control study
35 males with chronic low back pain and 32 controlExcessive paraspinal muscle fatigue by exerciseElectromyography, histomorphometry and immunohistochemistryParaspinal muscle dysfunction did not stem from a constitutionally predetermined adverse fiber type profile
[39]
Experimental research article
Nine healthy sedentary men not involved in strenuous eccentric exercise in past 6 monthsEccentric exercise induced muscle damageImmunohistochemistryDamage to Type II preceded damage to Type I fibers
[62]
Experimental study
Eight non-athletic young menIntensive eccentric knee flexion exerciseMuscle biopsies with suction, blood, and pain scoresType IIA fibers exhibit an 8% drop in peak force 5 h post-eccentric exercise, with no changes in Type I fibers; their stiffness response is influenced by the ACTN3 R577X polymorphism
[63]
Experimental study
20 healthy young menEccentric exerciseBlood creatine kinase The absence of α-actinin-3 is associated with greater muscle damage in Type II fibers
[64]
Case–control study
26 healthy male college students divide in two groupsMaximal eccentric exerciseElectromyographic activityReduced activation of fast-twitch motor units during the second eccentric bout
[65]
Experimental study
Two groups of 11 healthy male volunteersEccentric exercise-induced muscle damageCK, slow-twitch skeletal myosin heavy chains and cardiac troponin IClear damage was seen in Type I fibers, yet CK levels imply that Type II fibers were also involved, likely to a comparable extent
[38]
Experimental study
10 healthy men, no myotendinous injuries and no training programExercise induced muscle damageBlood sampling-ELISAConcentric-eccentric inertial exercise: sarcomere disruption in Type II fibers, while Type I fibers remain unaffected
[66]
Experimental study
10 recreationally trained young menResistance exercise Biopsies (glycogen depletion in Type I and II fibers), EMG, and anabolic signaling markersType I and II fibers were similarly activated regardless of load or repetition duration when exercise was performed to task failure, indicating that full motor unit recruitment occurs independent of load magnitude
Legend: ACTN3, α-actinine-3 gene; CK, blood creatine kinase; ELISA, enzyme-linked immunosorbent assay; h, hour.
Table 3. Comparison of Fiber Types in Pain and Dysfunction.
Table 3. Comparison of Fiber Types in Pain and Dysfunction.
AspectType I (Slow Twitch) FibersType II (Fast Twitch) Fibers (IIA/IIX)Type IIC (Transitional) Fibers
Satellite cell response to strength training↑ satellite cells↑↑ satellite cells
Stronger regenerative response
Can be influenced
Damage patternsCommon in repetitive work,
hypertrophied megafibers with poor capillarization
Often damaged first in eccentric/concentric-eccentric exercise,
sarcomere disruption and reduced force
May increase transiently
Symptoms (low back pain)Lower proportion with longer symptoms; presence of Type I megafibers linked to chronicityLonger symptoms linked to ↑ Type IIX and glycolytic profile; later shift sometimes toward more aerobic profile; contradictory findings across studiesRare in chronic pain; higher proportions seen in early (<1 year) symptoms suggesting early fiber transformation
Fiber size and atrophyChronic pain associated with smaller Type I fibersAtrophy often more pronounced; reduced strength potential; many studies report smaller Type II fibersNot typically described as selectively atrophied
Physical activity influenceNo clear differences across activity levelsNo clear differences across activity levelsNot found
Sex differencesWomen tend to have more Type I fibers; more megafibers in some pain conditions.Men tend to have more Type IIX fibers and larger fiber diameterNo clear evidence, probably fewer in women
Age tendenciesTendency toward higher proportion with agingAging tends to reduce fiber size and proportion, especially Type IIXNot found
Legend: ↑, increased; ↑↑, highly increased.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cardia, M.L.; Carneiro, B.D.; Tavares, I.; Pozza, D.H. Skeletal Fiber Type in Muscle Pain and Dysfunction. Biomedicines 2026, 14, 794. https://doi.org/10.3390/biomedicines14040794

AMA Style

Cardia ML, Carneiro BD, Tavares I, Pozza DH. Skeletal Fiber Type in Muscle Pain and Dysfunction. Biomedicines. 2026; 14(4):794. https://doi.org/10.3390/biomedicines14040794

Chicago/Turabian Style

Cardia, Maria Lopes, Bruno Daniel Carneiro, Isaura Tavares, and Daniel Humberto Pozza. 2026. "Skeletal Fiber Type in Muscle Pain and Dysfunction" Biomedicines 14, no. 4: 794. https://doi.org/10.3390/biomedicines14040794

APA Style

Cardia, M. L., Carneiro, B. D., Tavares, I., & Pozza, D. H. (2026). Skeletal Fiber Type in Muscle Pain and Dysfunction. Biomedicines, 14(4), 794. https://doi.org/10.3390/biomedicines14040794

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop